A recall of generic losartan tablets distributed by Teva Pharmaceuticals has been expanded after investigators detected high levels of NMBA in additional lots.…
A generic valsartan lawsuit claims recalled batches of the drugs contained impurities which led to kidney cancer.…
A generic valsartan lawsuit blames recalled tablets for the development of lung cancer and pancreatic cancer in a Kentucky man.…
In July 2018, it was discovered that certain generic valsartan pills sold for years may contain impurities that increase the risk of users developing liver cancer, kidney cancer and other side effects. …
A class action lawsuit accuses makers of generic valsartan of selling a misbranded and unadulterated drug that was never approved for sale in the United States, noting that the presence of cancer-causing impurities made it a different product from the original Diovan.…
A losartan recall class action lawsuit seeks reimbursement and medical monitoring for all who bought and used tablets tainted with a cancer-causing impurity.…
An FDA blog post says the agency is adequately protecting the country’s generic supply chain following months of recalls and claims by a former inspector that the agency is dropping the ball.…
A valsartan lawsuit claims generic versions of the hypertension drug caused the development of gastrointestinal cancer.…
A former FDA inspector says he tried to warn of valsartan problems long before the recalls were announced, and say they represent broader issues with the U.S. drug supply chain which are not being addressed.…
An FDA inspection has found numerous problems with quality control at a factory linked to recalled losartan tablets which contained cancer-causing impurities.…
